Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125242551 | 12524255 | 1 | I | 20160620 | 20160704 | 20160704 | EXP | CA-AUROBINDO-AUR-APL-2016-08644 | AUROBINDO | 45.00 | YR | M | Y | 0.00000 | 20160704 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125242551 | 12524255 | 1 | SS | CLOZAPINE. | CLOZAPINE | 1 | 150 MG, DAILY | U | U | 0 | 150 | MG | |||||||
125242551 | 12524255 | 2 | SS | CLOZAPINE. | CLOZAPINE | 1 | Unknown | 125 MG, DAILY | U | U | 0 | 125 | MG | ||||||
125242551 | 12524255 | 3 | PS | OLANZAPINE. | OLANZAPINE | 1 | U | 202050 | |||||||||||
125242551 | 12524255 | 4 | SS | QUETIAPINE. | QUETIAPINE | 1 | Unknown | 700 MG, DAILY | U | U | 0 | 700 | MG | ||||||
125242551 | 12524255 | 5 | SS | LEVOMEPROMAZINE | LEVOMEPROMAZINE | 1 | Unknown | U | U | 0 | |||||||||
125242551 | 12524255 | 6 | SS | PENFLURIDOL | PENFLURIDOL | 1 | Unknown | U | U | 0 | |||||||||
125242551 | 12524255 | 7 | SS | PIMOZIDE. | PIMOZIDE | 1 | Unknown | U | U | 0 | |||||||||
125242551 | 12524255 | 8 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | U | U | 0 | |||||||||
125242551 | 12524255 | 9 | C | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125242551 | 12524255 | 1 | Product used for unknown indication |
125242551 | 12524255 | 3 | Psychotic disorder |
125242551 | 12524255 | 4 | Product used for unknown indication |
125242551 | 12524255 | 5 | Psychotic disorder |
125242551 | 12524255 | 6 | Psychotic disorder |
125242551 | 12524255 | 7 | Psychotic disorder |
125242551 | 12524255 | 8 | Psychotic disorder |
125242551 | 12524255 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125242551 | 12524255 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125242551 | 12524255 | Adjustment disorder | |
125242551 | 12524255 | Agitation | |
125242551 | 12524255 | Akathisia | |
125242551 | 12524255 | Cognitive disorder | |
125242551 | 12524255 | Cogwheel rigidity | |
125242551 | 12524255 | Drug ineffective | |
125242551 | 12524255 | Eye movement disorder | |
125242551 | 12524255 | Fall | |
125242551 | 12524255 | Myoclonus | |
125242551 | 12524255 | Oculogyric crisis | |
125242551 | 12524255 | Parkinsonism | |
125242551 | 12524255 | Resting tremor | |
125242551 | 12524255 | Screaming | |
125242551 | 12524255 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |